With research laboratories around the world racing to develop a coronavirus vaccine, a unique challenge has emerged: how to balance intellectual property rights with serving the public good.
May 29, 2020
0
4
(HealthDay)—Multicancer blood testing combined with positron emission tomography-computed tomography (PET-CT) imaging can detect cancers, according to a study published online April 28 in Science to coincide with the virtual ...
Apr 29, 2020
0
0
The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.
Mar 30, 2020
0
6
The coronavirus has ground social, economic and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of the virus, but in the ...
Mar 27, 2020
0
3
A team of researchers at the University of Georgia are developing and testing new vaccines and immunotherapies to combat the novel coronavirus that has infected hundreds of thousands across the world.
Mar 25, 2020
0
3
(HealthDay)—Use of ex vivo lung perfusion (EVLP)-treated lungs increases the number of patients undergoing transplantation with comparable long-term outcomes, according to a study published online Oct. 9 in JAMA Surgery.
Oct 23, 2019
0
0
Professor John Whitelock is improving the smarts of antibodies and sending them into the extracellular area to outwit those clever cancer cells.
Oct 1, 2019
0
4
One of the main impediments in partnerships between the AI companies and biotechnology companies is contracting. Legal contracts for target identification and small molecule generation can be incredibly complex, especially ...
Jul 23, 2019
0
1
An antibody that targets and is taken up only by certain types of cancer cells has been developed by A*STAR researchers. Combining this antibody with an anticancer drug could lead to a new treatment for some types of breast ...
Jan 15, 2019
0
13
Recent announcements by two biotechnology companies have stoked fears that designer babies could soon be an option for those who can afford to pick and choose which features they want for their offspring. The companies, MyOme ...
